| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Adjuvant treatment of high-risk, radically resected gastric cancer patients with 5-fluorouracil, leucovorin, cisplatin, and epidoxorubicin in a randomized controlled trial. | J Natl Cancer Inst | 2007 | 2.42 |
| 2 | Colon cancer. | Crit Rev Oncol Hematol | 2010 | 1.62 |
| 3 | Incidence and clinical implications of venous thromboembolism in advanced colorectal cancer patients: the 'GISCAD-alternating schedule' study findings. | Eur J Cancer | 2008 | 0.85 |
| 4 | Chemotherapy in small bowel adenocarcinoma associated with celiac disease: a report of three cases. | Tumori | 2003 | 0.81 |
| 5 | The role of uracil-tegafur (UFT) in elderly patients with colorectal cancer. | Crit Rev Oncol Hematol | 2004 | 0.78 |
| 6 | Neoadjuvant chemotherapy for patients with liver metastases from colorectal cancer. | Expert Rev Anticancer Ther | 2007 | 0.77 |
| 7 | Is there an advantage for oral therapy in elderly? UFT. | Tumori | 2002 | 0.75 |